144 related articles for article (PubMed ID: 6246299)
1. Cytotoxicity on tumor cells of peripheral blood monocytes and tumor-associated macrophages in patients with ascites ovarian tumors.
Mantovani A; Polentarutti N; Peri G; Shavit ZB; Vecchi A; Bolis G; Mangioni C
J Natl Cancer Inst; 1980 Jun; 64(6):1307-15. PubMed ID: 6246299
[TBL] [Abstract][Full Text] [Related]
2. Tumoricidal activity of macrophages isolated from human ascitic and solid ovarian carcinomas: augmentation by interferon, lymphokines and endotoxin.
Peri G; Polentarutti N; Sessa C; Mangioni C; Mantovani A
Int J Cancer; 1981 Aug; 28(2):143-52. PubMed ID: 6172388
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxicity on tumour cells of human mononuclear phagocytes: defective tumoricidal capacity of alveolar macrophages.
Bordignon C; Avallone R; Peri G; Polentarutti N; Mangioni C; Mantovani A
Clin Exp Immunol; 1980 Aug; 41(2):336-42. PubMed ID: 6160006
[TBL] [Abstract][Full Text] [Related]
4. Natural cytotoxicity on tumour cells of human macrophages obtained from diverse anatomical sites.
Mantovani A; Bar Shavit Z; Peri G; Polentarutti N; Bordignon C; Sessa C; Mangioni C
Clin Exp Immunol; 1980 Mar; 39(3):776-84. PubMed ID: 6155233
[TBL] [Abstract][Full Text] [Related]
5. Natural killer activity of lymphoid cells isolated from human ascitic ovarian tumors.
Mantovani A; Allavena P; Sessa C; Bolis G; Mangioni C
Int J Cancer; 1980 May; 25(5):573-82. PubMed ID: 6154662
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of natural killer activity by tumor-associated lymphoid cells from ascites ovarian carcinomas.
Allavena P; Introna M; Mangioni C; Mantovani A
J Natl Cancer Inst; 1981 Aug; 67(2):319-25. PubMed ID: 6943371
[TBL] [Abstract][Full Text] [Related]
7. Intraperitoneal administration of Corynebacterium parvum in patients with ascitic ovarian tumors resistant to chemotherapy: effects on cytotoxicity of tumor-associated macrophages and NK cells.
Mantovani A; Sessa C; Peri G; Allavena P; Introna M; Polentarutti N; Mangioni C
Int J Cancer; 1981; 27(4):437-46. PubMed ID: 6168590
[No Abstract] [Full Text] [Related]
8. IL-2 enhances standard IFNgamma/LPS activation of macrophage cytotoxicity to human ovarian carcinoma in vitro: a potential for adoptive cellular immunotherapy.
Han X; Wilbanks GD; Devaja O; Ruperelia V; Raju KS
Gynecol Oncol; 1999 Nov; 75(2):198-210. PubMed ID: 10525372
[TBL] [Abstract][Full Text] [Related]
9. Effects on in vitro tumor growth of macrophages isolated from human ascitic ovarian tumors.
Mantovani A; Peri G; Polentarutti N; Bolis G; Mangioni C; Spreafico F
Int J Cancer; 1979 Feb; 23(2):157-64. PubMed ID: 761940
[TBL] [Abstract][Full Text] [Related]
10. Mononuclear-cell infiltration in ovarian cancer. III. Suppressor-cell and ADCC activity of macrophages from ascitic and solid ovarian tumours.
Haskill S; Koren H; Becker S; Fowler W; Walton L
Br J Cancer; 1982 May; 45(5):747-53. PubMed ID: 6211187
[TBL] [Abstract][Full Text] [Related]
11. Tumor cytolysis by lymphocytes infiltrating ovarian malignant ascites.
Ioannides CG; Platsoucas CD; Rashed S; Wharton JT; Edwards CL; Freedman RS
Cancer Res; 1991 Aug; 51(16):4257-65. PubMed ID: 1868446
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxicity on tumor cells of human macrophages: functional status of tumor-associated effector cells.
Mantovani A; Bordignon C; Biondi A; Introna M; Allavena P
Adv Exp Med Biol; 1982; 141():99-108. PubMed ID: 6178275
[No Abstract] [Full Text] [Related]
13. Tumor-associated macrophages as a source of functional dendritic cells in ovarian cancer patients.
Chu CS; Woo EY; Toll AJ; Rubin SC; June CH; Carroll RG; Schlienger K
Clin Immunol; 2002 Mar; 102(3):291-301. PubMed ID: 11890716
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the interaction of mononuclear phagocytes with ovarian carcinoma cells in a colony assay.
Peri G; Zanaboni F; Rossini S; Mangioni C; Landoni F; Epis A; Mantovani A
Br J Cancer; 1986 Jan; 53(1):47-52. PubMed ID: 3947515
[TBL] [Abstract][Full Text] [Related]
15. Defective antitumor function of monocyte-derived macrophages from epithelial ovarian cancer patients.
Gordon IO; Freedman RS
Clin Cancer Res; 2006 Mar; 12(5):1515-24. PubMed ID: 16533776
[TBL] [Abstract][Full Text] [Related]
16. Antibody-dependent and -independent cytotoxicity of human mononuclear phagocytes: defective stimulation of tumoricidal activity in milk macrophages.
Biondi A; Peri G; Colombo N; Bolis G; Mantovani A
Clin Exp Immunol; 1982 Sep; 49(3):701-8. PubMed ID: 7172502
[TBL] [Abstract][Full Text] [Related]
17. Lymphokine-activated killer activity of tumor-associated and peripheral blood lymphocytes isolated from patients with ascites ovarian tumors.
Allavena P; Zanaboni F; Rossini S; Merendino A; Bonazzi C; Vassena L; Mangioni C; Mantovani A
J Natl Cancer Inst; 1986 Oct; 77(4):863-8. PubMed ID: 3489856
[TBL] [Abstract][Full Text] [Related]
18. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
Colotta F; Peri G; Villa A; Mantovani A
J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
[TBL] [Abstract][Full Text] [Related]
19. Blood monocytes and tumor-associated macrophages in human cancer: differences in activation levels.
Baskic D; Acimovic L; Samardzic G; Vujanovic NL; Arsenijevic NN
Neoplasma; 2001; 48(3):169-74. PubMed ID: 11583284
[TBL] [Abstract][Full Text] [Related]
20. Intraperitoneal recombinant gamma-interferon in patients with recurrent ascitic ovarian carcinoma: modulation of cytotoxicity and cytokine production in tumor-associated effectors and of major histocompatibility antigen expression on tumor cells.
Allavena P; Peccatori F; Maggioni D; Erroi A; Sironi M; Colombo N; Lissoni A; Galazka A; Meiers W; Mangioni C
Cancer Res; 1990 Nov; 50(22):7318-23. PubMed ID: 2121337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]